Keyphrases
After Surgery
24%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
29%
Alzheimer's Disease
33%
Behavioral Weight Loss
31%
Body Mass Index
27%
Breast Cancer Survivors
40%
Cancer Patients
35%
Cetuximab
25%
Chemotherapy
29%
Clinical Outcomes
31%
Cluster Randomized Trial
58%
Comorbidity
21%
Computational Imaging
22%
Confidence Interval
77%
Decision Aid
22%
Diet Study
37%
Diffuse Large B-cell Lymphoma (DLBCL)
22%
Enhanced Recovery
27%
Generalized Estimating Equations
31%
Good Health
27%
Gynecologic Cancer Survivors
22%
Hazard Ratio
25%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
32%
Health Studies
37%
High Risk
26%
Multivariate Analysis
22%
Nab-paclitaxel
21%
Neoadjuvant
32%
NIH-AARP
37%
Non-small Cell Lung Cancer (NSCLC)
22%
Obese Women
22%
Obesity
30%
Odds Ratio
47%
Overall Survival
74%
Pancreatic Cancer
43%
Pancreatic Ductal Adenocarcinoma
28%
Pancreatic Neuroendocrine Tumors (pNETs)
22%
Pancreaticoduodenectomy
43%
Phase II Trial
24%
Prostate Cancer Risk
37%
Quality of Life
36%
Randomized Clinical Trial
23%
Randomized Controlled Trial
31%
Randomized Trial
34%
Recurrence-free Survival
27%
Relative Efficiency
25%
Stereotactic Body Radiation Therapy
22%
Symptom Experience
22%
Tumor
36%
Weight Loss
50%
Medicine and Dentistry
Acute Myeloid Leukemia
22%
Alzheimer's Disease
14%
Arm
24%
Biological Marker
17%
Body Mass Index
30%
Breast Cancer
49%
Cesarean Section
15%
Cetuximab
18%
Clinical Trial
39%
Computer Assisted Tomography
31%
Disease
31%
Endometrial Cancer
22%
Fibrosis
16%
Gemcitabine
19%
Hazard Ratio
15%
Head and Neck Cancer
14%
Head and Neck Squamous Cell Carcinoma
23%
Health Care Cost
35%
Lung Cancer
33%
Lung Transplantation
22%
Malignant Neoplasm
90%
Multivariate Analysis
21%
Neoplasm
100%
Neuroendocrine Tumor
32%
Neuroinflammation
14%
Non Small Cell Lung Cancer
14%
Obesity
32%
Odds Ratio
50%
Oncology
15%
Overall Survival
76%
Paclitaxel
23%
Pancreas Adenocarcinoma
39%
Pancreas Cancer
29%
Pancreaticoduodenectomy
47%
Patient-Reported Outcome
14%
Postoperative Complication
18%
Prevalence
16%
Prognostic Factor
21%
Progression Free Survival
25%
Quality of Life
26%
Radiation Therapy
29%
Randomized Clinical Trial
15%
Randomized Controlled Trial
31%
Recurrence Free Survival
24%
Recurrent Disease
29%
Stereotactic Radiosurgery
14%
Surgery
63%
Surgical Infection
15%
Transplantation
24%
Wart Virus
16%